Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

被引：0
|
作者：
Becky A. S. Bibby
Niluja Thiruthaneeswaran
Lingjian Yang
Ronnie R. Pereira
Elisabet More
Darragh G. McArt
Paul O’Reilly
Robert G. Bristow
Kaye J. Williams
Ananya Choudhury
Catharine M. L. West
机构：
[1] University of Manchester,Translational Radiobiology Group, Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health
[2] Manchester Academic Health Sciences Centre,Sydney Medical School
[3] The Christie NHS Foundation Trust,Translational Oncogenomics
[4] University of Sydney,Centre for Cancer Research and Cell Biology
[5] CRUK Manchester Institute and CRUK Manchester Centre,School of Pharmacy and Pharmaceutical Sciences
[6] Queen’s University Belfast,undefined
[7] University of Manchester,undefined
来源：
BMC Urology | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
    Kim, Kevin
    Zilbermintz, Leeor
    Martchenko, Mikhail
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14
  • [22] Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs
    Famurewa, Ademola C.
    Mukherjee, Anirban Goutam
    Wanjari, Uddesh Ramesh
    Sukumar, Aarthi
    Murali, Reshma
    Renu, Kaviyarasi
    Vellingiri, Balachandar
    Dey, Abhijit
    Gopalakrishnan, Abilash Valsala
    LIFE SCIENCES, 2022, 305
  • [23] Vaccination ethics and Repurposing approved drugs for cancer therapy
    Vetter, Norman
    BRITISH MEDICAL BULLETIN, 2021, 137 (01)
  • [24] Repurposing of approved cardiovascular drugs
    Ishida, Junichi
    Konishi, Masaaki
    Ebner, Nicole
    Springer, Jochen
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [25] Repurposing of approved cardiovascular drugs
    Junichi Ishida
    Masaaki Konishi
    Nicole Ebner
    Jochen Springer
    Journal of Translational Medicine, 14
  • [26] Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis
    Rani, Jyoti
    Silla, Yumnam
    Borah, Kasmika
    Ramachandran, Srinivasan
    Bajpai, Urmi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2521 - 2532
  • [27] In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
    Salaam, Ridwan Abiodun
    Afolayan, Funmilayo I. D.
    Olaniyi, Damilare Adebayo
    Oladokun, Sayo Ebenezer
    Ebuh, Rachael Pius
    Oyetunji, Ridwan Abiola
    SCIENTIFIC AFRICAN, 2025, 27
  • [28] Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
    Leung, Chung-Hang
    Chan, Daniel Shiu-Hin
    Kwan, Maria Hiu-Tung
    Cheng, Zhen
    Wong, Chun-Yuen
    Zhu, Guo-Yuan
    Fong, Wang-Fun
    Ma, Dik-Lung
    CHEMMEDCHEM, 2011, 6 (05) : 765 - 768
  • [29] Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
    Chopra, Sidharth
    Torres-Ortiz, Maria
    Hokama, Leslie
    Madrid, Peter
    Tanga, Mary
    Mortelmans, Kristien
    Kodukula, Krishna
    Galande, Amit K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2598 - 2601
  • [30] Structural Basis of Antisickling Effects of Selected FDA Approved Drugs: A Drug Repurposing Study
    Olubiyi, Olujide O.
    Olagunju, Maryam O.
    Oni, James O.
    Olubiyi, Abidemi O.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2018, 14 (02) : 106 - 116
12345